top of page

Manforce Condoms and Kartik Aaryan join forces to empower youth with consent education


Manforce Condoms and Kartik Aaryan join forces to empower youth with consent education

Mankind Pharma, a leading pharmaceutical company in India, is thrilled to announce the association of superstar Kartik Aaryan as the brand ambassador for Manforce Condoms. As the country's number one brand with a remarkable 30% market share, Mankind and Aaryan share a common vision of promoting meaningful conversations and dialogues surrounding consent in their latest campaign - "Apne partner se puchho"


Driven by its relentless pursuit to redefine pharmaceutical excellence in India, Mankind Pharma recognizes the influential role Kartik Aaryan plays, especially among the younger generation, making him the perfect ambassador to enlighten and sensitize audiences about the paramount significance of consent in today's society. The partnership aims to foster a greater understanding of consent through engaging and informative campaigns.


Speaking about his association with Manforce Condoms, Kartik Aryan shared, "I am glad to associate with Manforce Condoms, a brand that shares my vision of promoting consent and safe sexual practices. It is crucial to create awareness and initiate conversations about the importance of consent in today's society. I am excited to lend my voice to this cause and contribute towards a positive change. Together with Manforce Condoms, we aim to empower individuals to make informed choices and embrace safer sex practices for a healthier future."


Joy Chatterjee, AVP of Sales & Marketing, Mankind Consumer division commented, "We are privileged to have Kartik Aaryan as the brand ambassador for Manforce Condoms. As a superstar, he has garnered immense admiration both on-screen and off the silver screen. His messages resonate deeply with the youth, who view him as an idol. Kartik's ability to connect with and influence this demographic makes him a perfect fit to advocate for consent. At Manforce, we are acutely aware of the pressing need to elevate conversations around consent, and with Kartik's support, we are confident in our ability to reach a wider audience and drive positive change. Our upcoming campaign will continue our tradition of employing quirky and captivating marketing strategies that have previously disrupted the sensitive contraceptives category, further emphasizing our commitment to promoting sexual health and consent awareness."

Mankind Pharma continues to be socially responsible in its conversations around sexual health and the upcoming campaign around consent will seek to re-emphasize the same while spreading awareness to wider audiences.


Watch a promo here: https://youtu.be/KNqVcXoWxMk


About Mankind Pharma

Mankind Pharma (BSE: 543904 | NSE: MANKIND) is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices. The company is a leading player in the domestic pharmaceuticals business present across acute and chronic therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, VMN and respiratory, among others with a strategy to increase chronic presence going ahead. In the consumer healthcare business, the company operates in the condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories, among others, with several category-leading brands. The company has 25 manufacturing facilities across India and had 4,121 manufacturing personnel as of December 31, 2022. Manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products. Mankind has a consistent track record of product innovation, as of December 31, 2022, Company had a team of over 600 scientists and a dedicated in-house R&D center with four units located in IMT Manesar, Gurugram, Haryana and Thane, Maharashtra.


Mankind Pharma today, is India’s fourth largest pharmaceutical company in terms of Domestic Sales and third largest in terms of sales volume for MAT December 2022 (Source: IQVIA Dataset, IQVIA TSA MAT December 2022 Dataset for India (For FY20-22). The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

For more information, visit www.mankindpharma.com


Reach out to us at PR Desk

Read more on our Partner sites: Dais World | Growth Reports Business

Get rewarded for your reading habits on the Dais World app!

Comments


The Progress Catalyst

TPC3_edited.jpg

Throughout history, there have been individuals who have made a profound impact on the world. These individuals have pushed the boundaries of what is possible, and have made the world a better place for all. We will keep exploring the lives and work of these progress catalysts, and show how their contributions have shaped the world we live in today.

 

The Progress Catalyst is a celebration of these individuals. It is a tribute to their courage, their vision, and their determination. It is a reminder that we all have the power to make a difference in the world.

Posts Archive

Tags

bottom of page